Why ARCA Biopharma Shares Are Trading Higher Today
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Aug 19 2024
0mins
Should l Buy ?
Source: Benzinga
ARCA Biopharma's Special Dividend Announcement: ARCA Biopharma Inc (ABIO) shares rose by 12.5% to $3.32 after announcing a special dividend of $1.59 per share related to its merger with Oruka Therapeutics, contingent on stockholder approval and expected payment on August 28.
Investment Considerations for ABIO: Investors are advised to evaluate ABIO based on various factors including capital allocation programs, as the company does not currently pay dividends but may return value through buyback programs, with its stock showing a 52-week range between $1.56 and $4.49.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
